Robert Ilaria Jr. - 01 Sep 2021 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Chief Medical Officer
Signature
/s/ Robert Ilaria, Jr.
Issuer symbol
N/A
Transactions as of
01 Sep 2021
Net transactions value
$0
Form type
4
Filing time
03 Sep 2021, 21:03:00 UTC
Next filing
12 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +300,000 $0.000000 300,000 01 Sep 2021 Common Stock 300,000 $3.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 12/48th of the total number of shares on September 1, 2022 and vest as to 1/48th of the total number of shares at the end of each calendar month thereafter, provided that the Reporting Person continues to serve as the issuer's Chief Medical Officer on each vesting date.